Cargando…
The plasma glutamate concentration as a complementary tool to differentiate benign PET-positive lung lesions from lung cancer
BACKGROUND: Pulmonary imaging often identifies suspicious abnormalities resulting in supplementary diagnostic procedures. This study aims to investigate whether the metabolic fingerprint of plasma allows to discriminate between patients with lung inflammation and patients with lung cancer. METHODS:...
Autores principales: | Vanhove, K., Giesen, P., Owokotomo, O. E., Mesotten, L., Louis, E., Shkedy, Z., Thomeer, M., Adriaensens, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122613/ https://www.ncbi.nlm.nih.gov/pubmed/30176828 http://dx.doi.org/10.1186/s12885-018-4755-1 |
Ejemplares similares
-
Correlations between the metabolic profile and (18)F-FDG-Positron Emission Tomography-Computed Tomography parameters reveal the complexity of the metabolic reprogramming within lung cancer patients
por: Vanhove, Karolien, et al.
Publicado: (2019) -
Plausibility and redundancy analysis to select FDG‐PET textural features in non‐small cell lung cancer
por: Pfaehler, Elisabeth, et al.
Publicado: (2021) -
Changes in Metabolism as a Diagnostic Tool for Lung Cancer: Systematic Review
por: Mariën, Hanne, et al.
Publicado: (2022) -
Unraveling the Rewired Metabolism in Lung Cancer Using Quantitative NMR Metabolomics
por: Vanhove, Karolien, et al.
Publicado: (2022) -
Glutamine Addiction and Therapeutic Strategies in Lung Cancer
por: Vanhove, Karolien, et al.
Publicado: (2019)